Monopoly & lobbyists: Research reveals why US drugs are so pricey
Mylan and Turing are not “bad apples” but par for the course in the US pharmaceutical industry. Drug companies charge a fortune for medications because they can, doctors from the Harvard Medical School have argued in a prominent medical journal. Read Full Article at RT.com